CAND Journal

Multimodal Naturopathic Approach to Managing Musical Tinnitus: A Case Report

2025-11-19T13:27:31+00:00

Tinnitus, including the subtype musical tinnitus, can significantly impact quality of life. Musical tinnitus involves the perception of structured musical sounds without an external source and is often more distressing than typical tinnitus due to its intrusive nature. A 73-year-old female with a 12-year history of bilateral tinnitus presented with the recent onset of musical tinnitus in her left ear. The symptom was associated with significant emotional distress, insomnia, anxiety, and nausea. A multimodal treatment plan was implemented that included natural health products containing magnesium threonate, Ginkgo biloba, ginger, and other ingredients, in combination with acupuncture and homeopathy. After 6 weeks of treatment, the patient reported substantial improvement in musical tinnitus severity, sleep quality, anxiety, and nausea. This report documents a case of musical tinnitus where naturopathic medicine provided meaningful symptom relief. Further research is needed to explore the potential role of naturopathic medicine therapies in tinnitus management.

The Effect of Nutraceuticals on Incidence and Severity of Chemotherapy-Induced Peripheral Neuropathy: A Narrative Review

2026-01-07T09:24:59+00:00

Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of cancer treatments involving platinum and taxane agents such as paclitaxel, cisplatin, and oxaliplatin. This review evaluates the efficacy of three natural health products (NHPs)—omega-3 fatty acids, l-glutamine, and melatonin—on the incidence and severity of CIPN symptoms.

Methods: A search of PubMed was conducted from inception to October 2024. Inclusion criteria were human trials assessing the effect of either omega-3s, l-glutamine or melatonin on the incidence or severity of CIPN as a primary outcome, caused by platinum and taxane chemotherapy, with outcomes measured by clinical evaluations and scoring tools.

Results: Six clinical trials met the inclusion criteria. Of the included studies, three randomized controlled trials (RCTs) examined the effect of omega-3s, one RCT and one non-randomized trial examined l-glutamine, and one open-label pilot trial assessed melatonin. The participants enrolled in the studies did not have CIPN at baseline, with NHP administration starting during chemotherapy with some extending shortly after. Therefore, studies evaluated the effect of the NHPs on the incidence or severity of CIPN symptoms. Supplementation with omega-3 fatty acids and l-glutamine demonstrated statistically significant reductions in the incidence and severity of CIPN across multiple studies involving patients on paclitaxel and oxaliplatin regimens. In a small single-arm pilot study, melatonin use was associated with a lower neuropathy incidence, compared with historical incidence rates.

Discussion: Omega-3 fatty acids and l-glutamine, when used individually, may reduce the incidence and severity of neuropathic pain while supporting nerve function. However, a small number of relevant studies were identified, including small sample sizes and methodological limitations. Future research should include more human trials and further explore supplement safety, efficacy, and underlying mechanisms to establish integrative protocols for reducing the risk and severity of chemotherapy-induced neuropathy in cancer patients.

Naturopathic Doctors Must Speak Out Against Human Rights Atrocities in Palestine

2025-10-14T13:53:28+00:00

Saying Goodbye to CANDJ

2026-03-06T10:44:55+00:00